245 related articles for article (PubMed ID: 5032520)
1. The mechanism of folate transport in rabbit reticulocytes.
Bobzien WF; Goldman ID
J Clin Invest; 1972 Jul; 51(7):1688-96. PubMed ID: 5032520
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of 5-methyltetrahydrofolate transport by human erythrocytes.
Branda RF; Anthony BK; Jacob HS
J Clin Invest; 1978 May; 61(5):1270-5. PubMed ID: 659590
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
Henderson GB; Strauss BP
Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the membrane transport of folates by anions retained in uremia.
Jennette JC; Goldman ID
J Lab Clin Med; 1975 Nov; 86(5):834-43. PubMed ID: 1185041
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
6. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
Fry DW; Besserer JA; Boritzki TJ
Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
Zhao R; Gao F; Babani S; Goldman ID
Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
[TBL] [Abstract][Full Text] [Related]
8. Transport of methotrexate into PC-3 human prostate cancer cells.
Horne DW; Reed KA
Arch Biochem Biophys; 2001 Oct; 394(1):39-44. PubMed ID: 11566025
[TBL] [Abstract][Full Text] [Related]
9. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
Matherly LH; Czajkowski CA; Muench SP; Psiakis JT
Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
Sirotnak FM; Poser RE; Barrueco JR
Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
12. Uptake of folate and its analogue-amethopterin by mouse L-cells.
Grzelakowska-Sztabert B
Acta Biochim Pol; 1976; 23(4):309-20. PubMed ID: 1015153
[TBL] [Abstract][Full Text] [Related]
13. Expression of a folate binding protein in L1210 cells grown in low folate medium.
Jansen G; Kathmann I; Rademaker BC; Braakhuis BJ; Westerhof GR; Rijksen G; Schornagel JH
Cancer Res; 1989 Apr; 49(8):1959-63. PubMed ID: 2702638
[TBL] [Abstract][Full Text] [Related]
14. Transport, binding, and polyglutamation of methotrexate in freshly isolated rat hepatocytes.
Gewirtz DA; White JC; Randolph JK; Goldman ID
Cancer Res; 1980 Mar; 40(3):573-8. PubMed ID: 6162551
[TBL] [Abstract][Full Text] [Related]
15. Transport of folate compounds in L1210 cells: kinetic evidence that folate influx proceeds via the high-affinity transport system for 5-methyltetrahydrofolate and methotrexate.
Henderson GB; Suresh MR; Vitols KS; Huennekens FM
Cancer Res; 1986 Apr; 46(4 Pt 1):1639-43. PubMed ID: 3948153
[TBL] [Abstract][Full Text] [Related]
16. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells.
Bunni M; Doig MT; Donato H; Kesavan V; Priest DG
Cancer Res; 1988 Jun; 48(12):3398-404. PubMed ID: 3370638
[TBL] [Abstract][Full Text] [Related]
17. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
18. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo.
Sirotnak FM; Goutas LJ; Mines LS
Cancer Res; 1985 Oct; 45(10):4732-4. PubMed ID: 3875399
[TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
20. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]